Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Haematopoietic stem-cell transplantation in China in the era of targeted therapies: current advances, challenges, and future directions -

In the era of targeted therapies, haematopoietic stem-cell transplantation (HSCT), both allogeneic and autologous, remains a curative approach for patients with chemosensitive and immunesensitive

1597893224156495873

The Lancet Haematology

First, Ying-Jun Chang and colleagues discuss the development of haematopoietic stem-cell transplantation in China and the challenges faced. #HSCT #bmtsm https://t.co/ZBG6oNoIkK https://t.co/ZBG6oNoIkK - view on twitter

More coverage: #bmtsm #HSCT

Read the full article here

See more from The Lancet Haematology